BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33167975)

  • 1. Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).
    Samsom KG; Bosch LJW; Schipper LJ; Roepman P; de Bruijn E; Hoes LR; Riethorst I; Schoenmaker L; van der Kolk LE; Retèl VP; Frederix GWJ; Buffart TE; van der Hoeven JJM; Voest EE; Cuppen E; Monkhorst K; Meijer GA
    BMC Med Genomics; 2020 Nov; 13(1):169. PubMed ID: 33167975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early technology assessment of using whole genome sequencing in personalized oncology.
    Simons M; Van De Ven M; Coupé V; Joore M; IJzerman M; Koffijberg E; Frederix G; Uyl-De Groot C; Cuppen E; Van Harten W; Retèl V
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):343-351. PubMed ID: 33910430
    [No Abstract]   [Full Text] [Related]  

  • 3. Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice.
    Samsom KG; Schipper LJ; Roepman P; Bosch LJ; Lalezari F; Klompenhouwer EG; de Langen AJ; Buffart TE; Riethorst I; Schoenmaker L; Schout D; van der Noort V; van den Berg JG; de Bruijn E; van der Hoeven JJ; van Snellenberg H; van der Kolk LE; Cuppen E; Voest EE; Meijer GA; Monkhorst K
    J Pathol; 2022 Oct; 258(2):179-188. PubMed ID: 35792649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice.
    Samsom KG; Bosch LJW; Schipper LJ; Schout D; Roepman P; Boelens MC; Lalezari F; Klompenhouwer EG; de Langen AJ; Buffart TE; van Linder BMH; van Deventer K; van den Burg K; Unmehopa U; Rosenberg EH; Koster R; Hogervorst FBL; van den Berg JG; Riethorst I; Schoenmaker L; van Beek D; de Bruijn E; van der Hoeven JJM; van Snellenberg H; van der Kolk LE; Cuppen E; Voest EE; Meijer GA; Monkhorst K
    Nat Protoc; 2024 Mar; 19(3):700-726. PubMed ID: 38092944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study.
    van Opijnen MP; Broekman MLD; de Vos FYF; Cuppen E; van der Hoeven JJM; van Linde ME; Compter A; Beerepoot LV; van den Bent MJ; Vos MJ; Fiebrich HB; Koekkoek JAF; Hoeben A; Kho KH; Driessen CML; Jeltema HR; Robe PAJT; Maas SLN
    BMC Med Genomics; 2022 Nov; 15(1):233. PubMed ID: 36333718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical demands to use whole-genome sequencing in precision oncology.
    Meggendorfer M; Jobanputra V; Wrzeszczynski KO; Roepman P; de Bruijn E; Cuppen E; Buttner R; Caldas C; Grimmond S; Mullighan CG; Elemento O; Rosenquist R; Schuh A; Haferlach T
    Semin Cancer Biol; 2022 Sep; 84():16-22. PubMed ID: 34119643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole genome sequencing in oncology: using scenario drafting to explore future developments.
    van de Ven M; Simons MJHG; Koffijberg H; Joore MA; IJzerman MJ; Retèl VP; van Harten WH
    BMC Cancer; 2021 May; 21(1):488. PubMed ID: 33933021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing.
    Pasmans CTB; Tops BBJ; Steeghs EMP; Coupé VMH; Grünberg K; de Jong EK; Schuuring EMD; Willems SM; Ligtenberg MJL; Retèl VP; van Snellenberg H; de Bruijn E; Cuppen E; Frederix GWJ
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):413-414. PubMed ID: 33852815
    [No Abstract]   [Full Text] [Related]  

  • 10. A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias.
    Berglund E; Barbany G; Orsmark-Pietras C; Fogelstrand L; Abrahamsson J; Golovleva I; Hallböök H; Höglund M; Lazarevic V; Levin LÅ; Nordlund J; Norèn-Nyström U; Palle J; Thangavelu T; Palmqvist L; Wirta V; Cavelier L; Fioretos T; Rosenquist R
    Front Med (Lausanne); 2022; 9():842507. PubMed ID: 35402448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology.
    Rossen JWA; Friedrich AW; Moran-Gilad J;
    Clin Microbiol Infect; 2018 Apr; 24(4):355-360. PubMed ID: 29117578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.
    Simons MJHG; Retèl VP; Ramaekers BLT; Butter R; Mankor JM; Paats MS; Aerts JGJV; Mfumbilwa ZA; Roepman P; Coupé VMH; Uyl-de Groot CA; van Harten WH; Joore MA
    Pharmacoeconomics; 2021 Dec; 39(12):1429-1442. PubMed ID: 34405371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving potential of companion diagnostics.
    Khoury JD
    Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Operational models and criteria for incorporating microbial whole genome sequencing in hospital microbiology - A systematic literature review.
    Mintzer V; Moran-Gilad J; Simon-Tuval T
    Clin Microbiol Infect; 2019 Sep; 25(9):1086-1095. PubMed ID: 31039443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics.
    Roepman P; de Bruijn E; van Lieshout S; Schoenmaker L; Boelens MC; Dubbink HJ; Geurts-Giele WRR; Groenendijk FH; Huibers MMH; Kranendonk MEG; Roemer MGM; Samsom KG; Steehouwer M; de Leng WWJ; Hoischen A; Ylstra B; Monkhorst K; van der Hoeven JJM; Cuppen E
    J Mol Diagn; 2021 Jul; 23(7):816-833. PubMed ID: 33964451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited evolution of the actionable metastatic cancer genome under therapeutic pressure.
    van de Haar J; Hoes LR; Roepman P; Lolkema MP; Verheul HMW; Gelderblom H; de Langen AJ; Smit EF; Cuppen E; Wessels LFA; Voest EE
    Nat Med; 2021 Sep; 27(9):1553-1563. PubMed ID: 34373653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer.
    Simons MJHG; Uyl-de Groot CA; Retèl VP; Mankor JM; Ramaekers BLT; Joore MA; van Harten WH
    Value Health; 2023 Jan; 26(1):71-80. PubMed ID: 35973926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive pathology in routine diagnostics of solid tumors.
    Lassmann S; Werner M
    Histol Histopathol; 2012 Mar; 27(3):289-96. PubMed ID: 22237706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.
    Pruis MA; Groenendijk FH; Badloe KS; van Puffelen A; Robbrecht D; Dinjens WNM; Sleijfer S; Dingemans AC; von der Thüsen JH; Roepman P; Lolkema MP
    Br J Cancer; 2022 Sep; 127(4):776-783. PubMed ID: 35606463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
    Schipper LJ; Samsom KG; Snaebjornsson P; Battaglia T; Bosch LJW; Lalezari F; Priestley P; Shale C; van den Broek AJ; Jacobs N; Roepman P; van der Hoeven JJM; Steeghs N; Vollebergh MA; Marchetti S; Cuppen E; Meijer GA; Voest EE; Monkhorst K
    ESMO Open; 2022 Dec; 7(6):100611. PubMed ID: 36463731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.